 | • レポートコード：MRC2312MG09214 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、68ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の外陰部痛管理市場規模と予測を収録しています。・世界の外陰部痛管理市場：売上、2018年-2023年、2024年-2029年 ・世界の外陰部痛管理市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の外陰部痛管理市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 外陰部痛管理のグローバル主要企業は、Taro Pharmaceuticals U.S.A., Inc.、 Teva Pharmaceutical Industries Ltd.、 Acura Pharmaceuticals Inc.、 Purdue Pharma LP、 Alvogen Inc.、 Amneal Pharmaceuticals、 Mallinckrodt Pharmaceuticals、 Lupin Pharmaceuticals、 Alembic Pharmaceuticals、 Merck & Co., Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、外陰部痛管理のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の外陰部痛管理市場：タイプ別、2018年-2023年、2024年-2029年 世界の外陰部痛管理市場：タイプ別市場シェア、2022年 ・経口、皮下注射 世界の外陰部痛管理市場：用途別、2018年-2023年、2024年-2029年 世界の外陰部痛管理市場：用途別市場シェア、2022年 ・病院、専門診療所、その他 世界の外陰部痛管理市場：地域・国別、2018年-2023年、2024年-2029年 世界の外陰部痛管理市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における外陰部痛管理のグローバル売上、2018年-2023年 ・主要企業における外陰部痛管理のグローバル売上シェア、2022年 ・主要企業における外陰部痛管理のグローバル販売量、2018年-2023年 ・主要企業における外陰部痛管理のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Taro Pharmaceuticals U.S.A., Inc.、 Teva Pharmaceutical Industries Ltd.、 Acura Pharmaceuticals Inc.、 Purdue Pharma LP、 Alvogen Inc.、 Amneal Pharmaceuticals、 Mallinckrodt Pharmaceuticals、 Lupin Pharmaceuticals、 Alembic Pharmaceuticals、 Merck & Co., Inc. ************************************************************* ・調査・分析レポートの概要 外陰部痛管理市場の定義 市場セグメント 世界の外陰部痛管理市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の外陰部痛管理市場規模 世界の外陰部痛管理市場規模：2022年 VS 2029年 世界の外陰部痛管理市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの外陰部痛管理の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の外陰部痛管理製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：経口、皮下注射 外陰部痛管理のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、専門診療所、その他 外陰部痛管理の用途別グローバル売上・予測 ・地域別市場分析 地域別外陰部痛管理市場規模 2022年と2029年 地域別外陰部痛管理売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Taro Pharmaceuticals U.S.A., Inc.、 Teva Pharmaceutical Industries Ltd.、 Acura Pharmaceuticals Inc.、 Purdue Pharma LP、 Alvogen Inc.、 Amneal Pharmaceuticals、 Mallinckrodt Pharmaceuticals、 Lupin Pharmaceuticals、 Alembic Pharmaceuticals、 Merck & Co., Inc. ... |
This research report provides a comprehensive analysis of the Vulvodynia Pain Management market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Vulvodynia Pain Management market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Vulvodynia Pain Management, challenges faced by the industry, and potential opportunities for market players.
The global Vulvodynia Pain Management market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Vulvodynia Pain Management market presents opportunities for various stakeholders, including Hospital, Specialty Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Vulvodynia Pain Management market. Additionally, the growing consumer demand present avenues for market expansion.
The global Vulvodynia Pain Management market was valued at US$ 5289.7 million in 2022 and is projected to reach US$ 8058 million by 2029, at a CAGR of 6.6% during the forecast period.
Tailoring treatment plans to the specific needs and symptoms of each individual with vulvodynia continues to be a prominent trend. Advances in diagnostic techniques and better understanding of the subtypes of vulvodynia may lead to more precise and individualized treatment strategies.
Key Features:
The research report on the Vulvodynia Pain Management market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Vulvodynia Pain Management market.
Market Overview: The report provides a comprehensive overview of the Vulvodynia Pain Management market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral, Injection), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Vulvodynia Pain Management market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Vulvodynia Pain Management market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Vulvodynia Pain Management market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Vulvodynia Pain Management market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Vulvodynia Pain Management market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Vulvodynia Pain Management market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Vulvodynia Pain Management, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Vulvodynia Pain Management market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Vulvodynia Pain Management market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oral
Injection
Market segment by Application
Hospital
Specialty Clinic
Others
Global Vulvodynia Pain Management Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Taro Pharmaceuticals U.S.A., Inc.
Teva Pharmaceutical Industries Ltd.
Acura Pharmaceuticals Inc.
Purdue Pharma LP
Alvogen Inc.
Amneal Pharmaceuticals
Mallinckrodt Pharmaceuticals
Lupin Pharmaceuticals
Alembic Pharmaceuticals
Merck & Co., Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vulvodynia Pain Management, market overview.
Chapter 2: Global Vulvodynia Pain Management market size in revenue.
Chapter 3: Detailed analysis of Vulvodynia Pain Management company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vulvodynia Pain Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Vulvodynia Pain Management Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vulvodynia Pain Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vulvodynia Pain Management Overall Market Size
2.1 Global Vulvodynia Pain Management Market Size: 2022 VS 2029
2.2 Global Vulvodynia Pain Management Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Vulvodynia Pain Management Players in Global Market
3.2 Top Global Vulvodynia Pain Management Companies Ranked by Revenue
3.3 Global Vulvodynia Pain Management Revenue by Companies
3.4 Top 3 and Top 5 Vulvodynia Pain Management Companies in Global Market, by Revenue in 2022
3.5 Global Companies Vulvodynia Pain Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vulvodynia Pain Management Players in Global Market
3.6.1 List of Global Tier 1 Vulvodynia Pain Management Companies
3.6.2 List of Global Tier 2 and Tier 3 Vulvodynia Pain Management Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Vulvodynia Pain Management Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.2 By Type – Global Vulvodynia Pain Management Revenue & Forecasts
4.2.1 By Type – Global Vulvodynia Pain Management Revenue, 2018-2023
4.2.2 By Type – Global Vulvodynia Pain Management Revenue, 2024-2029
4.2.3 By Type – Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Vulvodynia Pain Management Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Specialty Clinic
5.1.4 Others
5.2 By Application – Global Vulvodynia Pain Management Revenue & Forecasts
5.2.1 By Application – Global Vulvodynia Pain Management Revenue, 2018-2023
5.2.2 By Application – Global Vulvodynia Pain Management Revenue, 2024-2029
5.2.3 By Application – Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Vulvodynia Pain Management Market Size, 2022 & 2029
6.2 By Region – Global Vulvodynia Pain Management Revenue & Forecasts
6.2.1 By Region – Global Vulvodynia Pain Management Revenue, 2018-2023
6.2.2 By Region – Global Vulvodynia Pain Management Revenue, 2024-2029
6.2.3 By Region – Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Vulvodynia Pain Management Revenue, 2018-2029
6.3.2 US Vulvodynia Pain Management Market Size, 2018-2029
6.3.3 Canada Vulvodynia Pain Management Market Size, 2018-2029
6.3.4 Mexico Vulvodynia Pain Management Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Vulvodynia Pain Management Revenue, 2018-2029
6.4.2 Germany Vulvodynia Pain Management Market Size, 2018-2029
6.4.3 France Vulvodynia Pain Management Market Size, 2018-2029
6.4.4 U.K. Vulvodynia Pain Management Market Size, 2018-2029
6.4.5 Italy Vulvodynia Pain Management Market Size, 2018-2029
6.4.6 Russia Vulvodynia Pain Management Market Size, 2018-2029
6.4.7 Nordic Countries Vulvodynia Pain Management Market Size, 2018-2029
6.4.8 Benelux Vulvodynia Pain Management Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Vulvodynia Pain Management Revenue, 2018-2029
6.5.2 China Vulvodynia Pain Management Market Size, 2018-2029
6.5.3 Japan Vulvodynia Pain Management Market Size, 2018-2029
6.5.4 South Korea Vulvodynia Pain Management Market Size, 2018-2029
6.5.5 Southeast Asia Vulvodynia Pain Management Market Size, 2018-2029
6.5.6 India Vulvodynia Pain Management Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Vulvodynia Pain Management Revenue, 2018-2029
6.6.2 Brazil Vulvodynia Pain Management Market Size, 2018-2029
6.6.3 Argentina Vulvodynia Pain Management Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Vulvodynia Pain Management Revenue, 2018-2029
6.7.2 Turkey Vulvodynia Pain Management Market Size, 2018-2029
6.7.3 Israel Vulvodynia Pain Management Market Size, 2018-2029
6.7.4 Saudi Arabia Vulvodynia Pain Management Market Size, 2018-2029
6.7.5 UAE Vulvodynia Pain Management Market Size, 2018-2029
7 Vulvodynia Pain Management Companies Profiles
7.1 Taro Pharmaceuticals U.S.A., Inc.
7.1.1 Taro Pharmaceuticals U.S.A., Inc. Company Summary
7.1.2 Taro Pharmaceuticals U.S.A., Inc. Business Overview
7.1.3 Taro Pharmaceuticals U.S.A., Inc. Vulvodynia Pain Management Major Product Offerings
7.1.4 Taro Pharmaceuticals U.S.A., Inc. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.1.5 Taro Pharmaceuticals U.S.A., Inc. Key News & Latest Developments
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd. Vulvodynia Pain Management Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Ltd. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.3 Acura Pharmaceuticals Inc.
7.3.1 Acura Pharmaceuticals Inc. Company Summary
7.3.2 Acura Pharmaceuticals Inc. Business Overview
7.3.3 Acura Pharmaceuticals Inc. Vulvodynia Pain Management Major Product Offerings
7.3.4 Acura Pharmaceuticals Inc. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.3.5 Acura Pharmaceuticals Inc. Key News & Latest Developments
7.4 Purdue Pharma LP
7.4.1 Purdue Pharma LP Company Summary
7.4.2 Purdue Pharma LP Business Overview
7.4.3 Purdue Pharma LP Vulvodynia Pain Management Major Product Offerings
7.4.4 Purdue Pharma LP Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.4.5 Purdue Pharma LP Key News & Latest Developments
7.5 Alvogen Inc.
7.5.1 Alvogen Inc. Company Summary
7.5.2 Alvogen Inc. Business Overview
7.5.3 Alvogen Inc. Vulvodynia Pain Management Major Product Offerings
7.5.4 Alvogen Inc. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.5.5 Alvogen Inc. Key News & Latest Developments
7.6 Amneal Pharmaceuticals
7.6.1 Amneal Pharmaceuticals Company Summary
7.6.2 Amneal Pharmaceuticals Business Overview
7.6.3 Amneal Pharmaceuticals Vulvodynia Pain Management Major Product Offerings
7.6.4 Amneal Pharmaceuticals Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.6.5 Amneal Pharmaceuticals Key News & Latest Developments
7.7 Mallinckrodt Pharmaceuticals
7.7.1 Mallinckrodt Pharmaceuticals Company Summary
7.7.2 Mallinckrodt Pharmaceuticals Business Overview
7.7.3 Mallinckrodt Pharmaceuticals Vulvodynia Pain Management Major Product Offerings
7.7.4 Mallinckrodt Pharmaceuticals Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.7.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.8 Lupin Pharmaceuticals
7.8.1 Lupin Pharmaceuticals Company Summary
7.8.2 Lupin Pharmaceuticals Business Overview
7.8.3 Lupin Pharmaceuticals Vulvodynia Pain Management Major Product Offerings
7.8.4 Lupin Pharmaceuticals Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.8.5 Lupin Pharmaceuticals Key News & Latest Developments
7.9 Alembic Pharmaceuticals
7.9.1 Alembic Pharmaceuticals Company Summary
7.9.2 Alembic Pharmaceuticals Business Overview
7.9.3 Alembic Pharmaceuticals Vulvodynia Pain Management Major Product Offerings
7.9.4 Alembic Pharmaceuticals Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.9.5 Alembic Pharmaceuticals Key News & Latest Developments
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Company Summary
7.10.2 Merck & Co., Inc. Business Overview
7.10.3 Merck & Co., Inc. Vulvodynia Pain Management Major Product Offerings
7.10.4 Merck & Co., Inc. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.10.5 Merck & Co., Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer